Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Placebo-controlled Trial of the Effects of Prophylactic Bifidobacterium Lactis HN019 Supplementation on the Incidence of Influenza Infection in Healthy Adults

NCT01258842 is registered in ClinicalTrials.gov with Fonterra Research Centre as lead sponsor.

NCT NCT01258842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01258842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Placebo-controlled Trial of the Effects of Prophylactic Bifidobacterium Lactis HN019 Supplementation on the Incidence of Influenza Infection in Healthy Adults
Lead sponsor
Fonterra Research Centre
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2010
Completion date
May 31, 2011
Enrollment
426 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza